Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SACRA: Empagliflozin in T2DM with Nocturnal Hypertension
NCT03050229Phase 4Completed
- Sponsor
- Jichi Medical University
- Start
- Jan 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in type 2 diabetes mellitus (T2DM), nocturnal hypertension (NH), sponsored by Jichi Medical University. Started Jan 2017; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)nocturnal hypertension (NH)
Beyond the preview
Go deeper on NCT03050229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050229.